Mr. Luc Tanguay has a long-standing experience and an enviable reputation in the finance and biotechnology sectors. Named President and Chief Executive Officer in 2012, he has been central to the strategy to buy back rights to EGRIFTA® in 2014, which allowed the Corporation to build its commercial platform. Since 1996, Mr. Tanguay has held various upper management positions at Theratechnologies, including Executive Vice President and Chief Financial Officer. Mr. Tanguay started his career in investment banking at Lévesque Beaubien (now National Bank Financial) where he helped several corporations to become publicly traded.
Mr. Tanguay holds a Bachelor’s and a Master’s degree in Finance from Université de Sherbrooke. He also obtained his Chartered Financial Analyst title from the University of Virginia.